ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.
Sleep Software Market To Hit USD 1,569.2 Million By 2030 With 10.1% CAGR Marketsandmarketstm
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.
What Is A 'Morning Shed' Routine, And Does It Actually Work?
Or could those jumping on the morning shed trend actually sabotage their beauty goals? We spoke to dermatologists and hair ...
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, ...